11/05/2026
[English Below]
แแทแ
แแ
แแแแแปแแแฝแแแแแถแแแถแแแแแแแแแถแแทแแถแแแแแฝแแแทแแทแแแแแทแแแแแแ แแทแแแปแแแแแทแแถแ (DSMB) แแทแแแแแแแแแถแแทแแถแแแนแแแถแแแแแแแ DATURA แแแแแถแแแแแแแแนแแแแแ
แแ
แแธแแแแปแ Montpellier แแแแแแแแถแแถแแ
แแแแแแแแแแถแแแแแถแแแแแแแแถแแแแแ DATURA (NCT04738812) แแถแแแถแแแแแแแแถแแแแถแแแแแแแถแแแแฝแ แแบแแถแแแแแ
แแแแถแแแทแแถแแแทแแแแแแ แแทแแแถแแแทแแทแแแแกแพแแแทแแแผแแแแแแแแแแ แแแแปแแขแแกแปแแแแแแทแ
แแ
แแแแแปแ แแแแแแแแถแแทแแถแแแนแแแถแแแแแแแ แแ
แแธแแแแปแ Montpellier แแแแแแแแถแแถแแ แแถแแแธแแแแแแธ แขแง-แขแจ แแแแแแถ แแแแถแ แขแ แขแฆแ
แแแแแแแถแแงแแแแแแแแแแทแแถแแแ ANRS แแทแ EDCTP2 แแแแแแ DATURA แแบแแถแแถแแแถแแแแแแแแแธแแทแแขแแแแแแถแแทแแแแถแแแแถแแแธ แฃ (Phase III clinical trial) แแแแแแแผแแแถแแขแแปแแแแแแ
แแแแปแแแแแแแแแแแแปแแถ แแทแแแแแแแแ
แแแฝแ แฅ แแแแแแแปแแแแแธแแขแถแ แแแแแทแ แแฝแแแถแแ แแแแแแแแถแแแแผแ แ แแแธแแ แขแแผแ แแแแแแถ แ แแแถแแแแธ แแทแแแแผแแแแแธแแ แแถแแแทแแแแถแแแแแถแแแแแแแแแแถแแแแแแแแถ แแพแแถแแแแแถแแถแแแแแบแแแแแแแแปแแแแแแทแแแแแถแแ (intensified treatment) แขแถแ
แแถแแแแแแแแขแแแแถแแแแแถแแแแแปแแ
แแแแแแแปแแแแแแแแแ แแทแแแแปแแแแแแแแแแแแแแแแแแแถแแแแแถแแถแแแแแปแแแแแแธแแแแแแ แ แพแแแถแแแแแปแแแแแแแขแแแแแแแแปแแแแแถแแแแถแแแแแแแแแแแแถแแแแแฌแแแ
แแแแปแแขแแกแปแแแแแแทแ
แแ
แแแแแปแ แแแแปแแแถแแแถแแแแแถแแแแแถแแแแแแแแถแแแแแ แแแแแแขแแแธแแแแธแแถแแแแแ แแทแแแปแแแถแแแถแแถแแแแแแแทแแแแถแแแแถแแแแถแแแแแแแแแแปแแถ แแถแแ
แแแแแแแแแผแแแแแทแแแแแแแแแถแแแแแแแปแแแถแแขแแปแแแแ แแทแแแปแแแแแถแแแแแแแแแแทแแแแแทแแถแแแแแแถแแแแแ
แแกแพแแแแแปแแขแแกแปแแแแแแทแแแแถ แแแแแแแแแแแแแแแแพแแถแแแแแแถแแแแแแทแ
แแ
แแแแแแแแแแฝแแแแแนแแแถแ แแถแแแแแแแแแแแแทแแแแแแแแแแแแแแแแปแแแถแ แแทแแแถแแแแ
แทแแแแแปแแแถแแแแแแแแแพแขแแแแแแแบ (patient-centered care) แแ
แแแแปแแแแทแแแแแแถแแแแแถแแแแแถแแแแแแแแถแแแแแแแแแแแปแแแแแถแแ
แแทแ
แแ
แแ แแถแแแแแแบแแถแแแ แถแแแแแแแถแแแแฝแแแแแแแแ
แแแแถแแแแแแนแแแทแแธแแถแแแแแแแแขแแแแพแแแแแปแแถแแแทแแแแถแแถแแแแแ แแแแแถแแแแถแแแแแถแแถแแแถแแแแแแแฝแแแแแถแแแถแแแแแบแแแแ แแทแแแแแแแขแแแแแแแแถแแแแถแแแแแแแแแแ แแแแแแถแแแแฝแแแแแแนแแแแแแแแแแถแแแถแแแแผแแทแแแแถแแถแแแแแแขแแแแแแถแแทแแแแแแ
แแพแแแผแแขแแขแแแถแแแแแแขแแแแแแแถแแแแแถแ แแแแผแแแแแ แแแแปแแแถแแแถแแ
แปแแแแแถแแแแแแแธแแถแแ แแทแแแแแผแแถแแแแแแแแแถแแแขแแ แแแแแถแแ
แผแแแฝแแ
แแแแแแแแแแ
แแถแแแผแแแแทแแแแแแแแ แ แพแแแพแแแแแแนแแแแแ
แถแแแถแแ
แแแแแแถแแขแแแแแแแทแแแแถแแถแแแแแ แแทแแแถแแแแแแแแแแแถแแแผแแแแแแแแแแแถแแแทแแแแถแแแแแถแแแแแถแแแแแถแแแปแแ
Joint meeting of the DATURA DSMB and Project Steering Committee Held in Montpellier, France
The DATURA Clinical Research project (NCT04738812) has reached an important milestone with the completion of the data analysis phase and the review of preliminary results during the Project Steering Committee meeting in Montpellier, France, on 27-28 April 2026.
Funded by ANRS and EDCTP2, DATURA is an international Phase III clinical trial conducted across Cambodia and five African countries โ Cameroon, Guinea, Uganda, Zambia, and Mozambique โ to evaluate whether intensified anti-tuberculosis treatment can reduce mortality among hospitalized adults and adolescents living with advanced HIV.
During the meeting, Ms. Sopheavet In, the study coordinator of the Clinical Research Group of the Epidemiology and Public Health Unit of IPC has shared key implementation experiences and operational strategies developed throughout the study, highlighting the importance of strong coordination, quality data management, and patient-centered care in complex clinical research settings.
This collaboration marks an important step toward strengthening evidence-based approaches for TB and advanced HIV co-infection, while reinforcing the value of international scientific partnerships.
We congratulate all investigators, clinicians, field teams, and partners involved in reaching this milestone, and we look forward to the upcoming scientific publications and the dissemination of findings.